We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+3.58%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$251M
AUM Growth
+$17.5M
(+7.5%)
Cap. Flow
+$12.1M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
73.45%
Holding
118
New
10
Increased
17
Reduced
7
Closed
9
Avg Time Held
1.9
years
Top 10 Avg Time Held
2
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$8.13M |
| 2 |
FTAI Aviation
FTAI
|
+$4.74M |
| 3 |
Upland Software
UPLD
|
+$3.95M |
| 4 |
Viking Therapeutics
VKTX
|
+$674K |
| 5 |
QTNT
Quotient Limited Ordinary Shares
QTNT
|
+$476K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$4.88M |
| 2 |
Pfizer
PFE
|
+$1.63M |
| 3 |
ATCO
Atlas Corp.
ATCO
|
+$993K |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$752K |
| 5 |
SHPG
Shire pic
SHPG
|
+$460K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.78% |
| 2 | Financials | 7.67% |
| 3 | Technology | 5.89% |
| 4 | Energy | 5.67% |
| 5 | Industrials | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Ligand Pharmaceuticals
LGND
$5.85B
| $104M | 41.55% |
1,222,999
-56,355
| -4% | -$4.88M |
2013 Q2
18 quarters
|
|
|
2
Pfizer
PFE
$168B
| $33.8M | 13.44% |
983,673
-47,852
| -5% | -$1.63M |
2013 Q2
18 quarters
|
|
3
Capitol Federal Financial
CFFN
$1.01B
| $9.26M | 3.68% |
690,400
| – | – |
2013 Q2
18 quarters
|
|
|
4
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $8.49M | 3.38% |
132,300
+120,000
| +976% | +$8.13M |
2014 Q2
14 quarters
|
|
5
Microsoft
MSFT
$3.91T
| $5.88M | 2.34% |
68,750
| – | – |
2013 Q2
18 quarters
|
|
|
6
FTAI Aviation
FTAI
$17.3B
| $5.14M | 2.04% |
+302,001
| New | +$4.74M |
2017 Q4
0 quarters
|
|
7
AbbVie
ABBV
$504B
| $5.08M | 2.02% |
52,500
| – | – |
2015 Q2
10 quarters
|
|
8
DELISTED
Anadarko Petroleum
APC
| $4.32M | 1.72% |
80,760
| – | – |
2013 Q2
18 quarters
|
|
9
Apple
AAPL
$5.01T
| $4.24M | 1.69% |
100,200
| – | – |
2013 Q2
18 quarters
|
|
10
Iridium Communications
IRDM
$4.69B
| $3.99M | 1.59% |
338,000
| – | – |
2014 Q2
14 quarters
|
|
|
11
Upland Software
UPLD
$8.37M
| $3.9M | 1.55% |
+18,000
| New | +$3.95M |
2017 Q4
0 quarters
|
|
12
Delta Air Lines
DAL
$50.1B
| $3.22M | 1.28% |
57,500
| – | – |
2015 Q4
8 quarters
|
|
13
DuPont de Nemours
DD
$17.7B
| $2.68M | 1.07% |
14,865
| – | – |
2015 Q1
11 quarters
|
|
14
Howard Hughes
HHH
$4.12B
| $2.63M | 1.04% |
20,980
| – | – |
2017 Q2
2 quarters
|
|
15
JPMorgan Chase
JPM
$900B
| $2.46M | 0.98% |
23,050
| – | – |
2013 Q2
18 quarters
|
|
16
Octave Specialty Group
OSG
$209M
| $2.32M | 0.92% |
145,426
| – | – |
2013 Q2
18 quarters
|
|
|
RXDX
17
DELISTED
Ignyta, Inc.
RXDX
| $1.81M | 0.72% |
67,700
| – | – |
2017 Q3
1 quarter
|
|
18
CoreCivic
CXW
$3.03B
| $1.69M | 0.67% |
75,000
| – | – |
2016 Q4
4 quarters
|
|
19
Community Healthcare Trust
CHCT
$381M
| $1.69M | 0.67% |
60,000
| – | – |
2015 Q2
10 quarters
|
|
20
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.49M | 0.59% |
380,110
+15,000
| +4% | +$49.6K |
2017 Q1
3 quarters
|
|
|
AVDL
21
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.3M | 0.52% |
158,555
| – | – |
2015 Q4
8 quarters
|
|
|
CNCE
22
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.28M | 0.51% |
49,557
+4,557
| +10% | +$91.8K |
2017 Q3
1 quarter
|
|
23
AllianceBernstein
AB
$3.19B
| $1.26M | 0.5% |
50,500
| – | – |
2013 Q2
18 quarters
|
|
24
The Kraft Heinz Company
KHC
$27.8B
| $1.24M | 0.49% |
15,900
| – | – |
2015 Q3
9 quarters
|
|
|
ENFC
25
DELISTED
Entegra Financial Corp.
ENFC
| $1.18M | 0.47% |
40,250
| – | – |
2014 Q4
12 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q4 2017 Portfolio in Review
As of Q4 2017, David M. Knott held 118 positions worth $251M, up 7.5% from $234M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
David M. Knott deployed $12.1M of net new capital in Q4 2017, opening 10 new positions and adding to 17 existing holdings. Its largest new stake was FTAI Aviation: 302,001 shares worth $5.14M.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, down from 70% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $4.88M trimmed.
- David M. Knott's largest Q4 2017 buy was FTAI Aviation: 302,001 shares worth $5.14M.
- David M. Knott added most to Macquarie Infrastructure Holdings, LLC in Q4 2017, an estimated $8.13M increase.
- David M. Knott's biggest Q4 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $4.88M.
- David M. Knott fully exited Atlas Corp. in Q4 2017, selling an estimated $993K.
- David M. Knott's ten largest holdings make up 73% of its $251M portfolio in Q4 2017.
- David M. Knott opened 10 new positions and closed 9 in Q4 2017.
- David M. Knott's portfolio value rose 7.5% quarter-over-quarter to $251M.
Based on David M. Knott's 13F filing for Q4 2017, filed 13 Feb 2018.